Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Stephane St-Onge"'
Autor:
Wei Zhongyong, Johan Broddefalk, Madeleine Antonsson, Kosrat Amin, Jörgen Jensen, Johan Ulander, Maxime Tremblay, Stephane St-Onge, Karolina Nilsson, Shujuan Jin, Anders Lehmann, Alleyn T. Plowright, Christopher Walpole, Tomaszewski Miroslaw, Hua Yang
Publikováno v:
Journal of Medicinal Chemistry. 56:220-240
Agonists of the cannabinoid receptor 1 (CB1) have been suggested as possible treatments for a range of medical disorders including gastroesophageal reflux disease (GERD). While centrally acting cannabinoid agonists are known to produce psychotropic e
Autor:
Xuehong Luo, Xiao Hong Yu, Pourashraf Mehrnaz, Sanjay Srivastava, Dominic Salois, Cheng Yun-Xing, Kemal Payza, Christopher Walpole, Etienne Lessard, Stephane St-Onge, Tomaszewski Miroslaw
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:1619-1624
An oral, peripherally restricted CB1/CB2 agonist could provide an interesting approach to treat chronic pain by harnessing the analgesic properties of cannabinoids but without the well-known central side effects. γ-Carbolines are a novel class of po
Autor:
Wei Zhongyong, Mirek Tomaszewski, Helene AstraZeneca R D Montreal Desfosses, Thierry Hong Groblewski, Page Daniel, Rosemarie Panetta, Etienne Lessard, Maxime Tremblay, William Brown, Stephane St-Onge, Claire Milburn, Sanjay K. Srivastava, Xiao Hong Yu, Kemal Payza, Hua Yang, Walpole Christopher, Ziping Liu
Publikováno v:
Letters in Drug Design & Discovery. 7:208-213
Autor:
Martin Coupal, Paul Jones, Lejla Hodzic, Wenhau Xiao, Edward Roberts, Andrew Griffin, Daniel Delorme, Dominic Salois, Maryse Labarre, Stephane St-Onge, Christopher Walpole, Jamie Boulet, Lars Gawell, Rico Lavoie, Joanne Butterworth, William Brown
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:5994-5998
We have investigated a series of phenolic diaryl amino piperidine delta opioid receptor agonists, establishing the importance of the phenol functional group and substitution on the piperdine nitrogen for delta agonist activity and selectivity versus
Publikováno v:
Letters in Drug Design & Discovery. 3:298-303
Autor:
William Brown, Tomaszewski Miroslaw, Etienne Lessard, Christopher Walpole, Wei Zhongyong, Hua Yang, Beha Sara, Sanjay Srivastava, Maxime Tremblay, Shi Yi Yue, Shawn Johnstone, Stephane St-Onge, Thierry Groblewski, Anne-Julie Archambault, Ziping Liu, Page Daniel
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(12)
Cannabinoid CB1 receptor agonists exhibit potent analgesic effects in rodents and humans, but their clinical utility as analgesic drugs is often limited by centrally mediated side effects. We report herein the preparation of N-methyl-3-(tetrahydro-2H
Autor:
Jennifer M. A. Laird, Giovanni Martino, Anne Morinville, Stephane St-Onge, Chang Qing Cao, Carole Puma, Etienne Lessard, Xiao Hong Yu, Martin N. Perkins
Publikováno v:
PainReferences. 151(2)
Cannabinoids are analgesic in man, but their use is limited by their psychoactive properties. One way to avoid cannabinoid receptor subtype 1 (CB1R)-mediated central side-effects is to develop CB1R agonists with limited CNS penetration. Activation of
Autor:
Page Daniel, Christopher Walpole, François Gaudreault, Meredith Fyfe, Hua Yang, Manon Fleurent, Stephane St-Onge, William Brown
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(22)
The preparation and evaluation of a novel class of CB2 agonists based on a 1,2,3,4-tetrahydropyrrolo[3,4-b]indole moiety are reported. They showed binding affinities up to 4.2 nM toward CB2 with sub-nanomolar EC50 values. They also showed moderate to
Autor:
Wei Zhongyong, Fei Zhou, Stephane St-Onge, Daniel Delorme, Pierre-Emmanuel Morin, Ralf Schmidt, Christopher Walpole, Maryse Labarre, Julie Ducharme, Benjamin Pelcman, Denis Projean, Kemal Payza, Shi Yi Yue, Helene Gagnon, Hua Yang, William Brown, Lars Gawell, Augustus Kamassah, Edward Roberts, Edward Zhou, Niklas Plobeck, Peter Schwarz
Publikováno v:
Journal of medicinal chemistry. 43(21)
Nonpeptide delta opioid agonists are analgesics with a potentially improved side-effect and abuse liability profile, compared to classical opioids. Andrews analysis of the NIH nonpeptide lead SNC-80 suggested the removal of substituents not predicted
Autor:
William Brown, Claude Godbout, Denis Projean, Bryan K. Takasaki, Ralf Schmidt, Joanne Butterworth, Wei Zhongyong, Helene Gagnon, Lars Gawell, Pierre-Emmanuel Morin, Chris Walpole, Daniel Delorme, Hua Yang, Julie Ducharme, Edward Roberts, Paul Jones, Maryse Labarre, Shi-Yi Yue, Andrea Jakob, Augustus Kamassah, Kemal Payza, Niklas Plobeck, Fei Zhou, Stephane St-Onge
Publikováno v:
Journal of medicinal chemistry. 43(21)
The design, synthesis, and pharmacological evaluation of a novel class of delta opioid receptor agonists, N, N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide (6a) and its analogues, are described. These compounds, formally derived from SNC-80 (